Capitalbio Tech

Developer of microfluidic chips for the treatment of multiple diseases

placeBeijing, Beijing, China calendar_todayFounded 2012 groups2,000 employees language capitalbiotech.com

Innovation

6 patent families (3 granted) — focus: Operations & transport, Chemistry & metallurgy, Physics & computing; filing pace slowing. Cited 155 times.

YearFilings
20172
20181
20191
20211
20231

Investor mix

10 investors on record; lead investors include Sinopec Shanghai Petrochemical Company Limited, Health 100, New Alliance Capital, Red Horse Investment Group.

Investor typeCountShare
Venture capital330%
Private equity330%
Bank & private debt110%
Other / undisclosed330%
Coming soon